vs
GULFPORT ENERGY CORP（GPOR）与Revvity（RVTY）财务数据对比。点击上方公司名可切换其他公司
Revvity的季度营收约是GULFPORT ENERGY CORP的1.9倍（$772.1M vs $398.2M），GULFPORT ENERGY CORP净利率更高（33.3% vs 12.7%，领先20.5%），GULFPORT ENERGY CORP同比增速更快（66.0% vs 5.9%），过去两年GULFPORT ENERGY CORP的营收复合增速更高（18.6% vs 9.0%）
Gulfport Energy Corp是一家总部位于美国的独立油气勘探生产企业，核心运营区域覆盖俄亥俄州尤蒂卡页岩区、俄克拉荷马州SCOOP产区，主要生产天然气、原油及天然气液，供应北美工业、公用事业及商业终端市场。
Revvity是一家美国生命科学与诊断领域企业，主要服务制药、生物技术行业客户，重点围绕细胞治疗、基因治疗等前沿技术领域提供相关产品与解决方案，其前身为业务布局多元的老牌企业珀金埃尔默。
GPOR vs RVTY — 直观对比
营收规模更大
RVTY
是对方的1.9倍
$398.2M
营收增速更快
GPOR
高出60.1%
5.9%
净利率更高
GPOR
高出20.5%
12.7%
两年增速更快
GPOR
近两年复合增速
9.0%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $398.2M | $772.1M |
| 净利润 | $132.4M | $98.4M |
| 毛利率 | 76.6% | — |
| 营业利润率 | 44.9% | 14.5% |
| 净利率 | 33.3% | 12.7% |
| 营收同比 | 66.0% | 5.9% |
| 净利润同比 | 148.5% | 3.9% |
| 每股收益（稀释后） | $7.98 | $0.86 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收GPORRVTY
| Q4 25 | $398.2M | $772.1M | ||
| Q3 25 | $379.7M | $698.9M | ||
| Q2 25 | $447.6M | $720.3M | ||
| Q1 25 | $197.0M | $664.8M | ||
| Q4 24 | $239.9M | $729.4M | ||
| Q3 24 | $253.9M | $684.0M | ||
| Q2 24 | $181.1M | $691.7M | ||
| Q1 24 | $283.2M | $649.9M |
净利润GPORRVTY
| Q4 25 | $132.4M | $98.4M | ||
| Q3 25 | $111.4M | $46.7M | ||
| Q2 25 | $184.5M | $53.9M | ||
| Q1 25 | $-464.0K | $42.2M | ||
| Q4 24 | $-273.2M | $94.6M | ||
| Q3 24 | $-14.0M | $94.4M | ||
| Q2 24 | $-26.2M | $55.4M | ||
| Q1 24 | $52.0M | $26.0M |
毛利率GPORRVTY
| Q4 25 | 76.6% | — | ||
| Q3 25 | 74.6% | 53.6% | ||
| Q2 25 | 80.7% | 54.5% | ||
| Q1 25 | 57.9% | 56.5% | ||
| Q4 24 | 63.2% | — | ||
| Q3 24 | 64.6% | 56.3% | ||
| Q2 24 | 52.2% | 55.7% | ||
| Q1 24 | 69.4% | 54.6% |
营业利润率GPORRVTY
| Q4 25 | 44.9% | 14.5% | ||
| Q3 25 | 41.9% | 11.7% | ||
| Q2 25 | 56.0% | 12.6% | ||
| Q1 25 | 6.1% | 10.9% | ||
| Q4 24 | -131.3% | 16.3% | ||
| Q3 24 | 5.7% | 14.3% | ||
| Q2 24 | -10.0% | 12.4% | ||
| Q1 24 | 28.9% | 6.8% |
净利率GPORRVTY
| Q4 25 | 33.3% | 12.7% | ||
| Q3 25 | 29.3% | 6.7% | ||
| Q2 25 | 41.2% | 7.5% | ||
| Q1 25 | -0.2% | 6.4% | ||
| Q4 24 | -113.9% | 13.0% | ||
| Q3 24 | -5.5% | 13.8% | ||
| Q2 24 | -14.5% | 8.0% | ||
| Q1 24 | 18.4% | 4.0% |
每股收益（稀释后）GPORRVTY
| Q4 25 | $7.98 | $0.86 | ||
| Q3 25 | $4.45 | $0.40 | ||
| Q2 25 | $9.12 | $0.46 | ||
| Q1 25 | $-0.07 | $0.35 | ||
| Q4 24 | $-14.72 | $0.77 | ||
| Q3 24 | $-0.83 | $0.77 | ||
| Q2 24 | $-1.51 | $0.45 | ||
| Q1 24 | $2.34 | $0.21 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $1.8M | $919.9M |
| 总债务越低越好 | $788.2M | — |
| 股东权益账面价值 | $1.8B | $7.3B |
| 总资产 | $3.0B | $12.2B |
| 负债/权益比越低杠杆越低 | 0.43× | — |
8季度趋势，按日历期对齐
现金及短期投资GPORRVTY
| Q4 25 | $1.8M | $919.9M | ||
| Q3 25 | $3.4M | $931.4M | ||
| Q2 25 | $3.8M | $991.8M | ||
| Q1 25 | $5.3M | $1.1B | ||
| Q4 24 | $1.5M | $1.2B | ||
| Q3 24 | $3.2M | $1.2B | ||
| Q2 24 | $1.2M | $2.0B | ||
| Q1 24 | $8.2M | $1.7B |
总债务GPORRVTY
| Q4 25 | $788.2M | — | ||
| Q3 25 | $691.7M | — | ||
| Q2 25 | $695.2M | — | ||
| Q1 25 | $700.4M | — | ||
| Q4 24 | $702.9M | — | ||
| Q3 24 | $694.4M | — | ||
| Q2 24 | $679.5M | — | ||
| Q1 24 | $636.4M | — |
股东权益GPORRVTY
| Q4 25 | $1.8B | $7.3B | ||
| Q3 25 | $1.8B | $7.4B | ||
| Q2 25 | $1.8B | $7.6B | ||
| Q1 25 | $1.7B | $7.6B | ||
| Q4 24 | $1.7B | $7.7B | ||
| Q3 24 | $2.1B | $7.9B | ||
| Q2 24 | $2.1B | $7.9B | ||
| Q1 24 | $2.2B | $7.8B |
总资产GPORRVTY
| Q4 25 | $3.0B | $12.2B | ||
| Q3 25 | $2.9B | $12.1B | ||
| Q2 25 | $3.0B | $12.4B | ||
| Q1 25 | $2.9B | $12.4B | ||
| Q4 24 | $2.9B | $12.4B | ||
| Q3 24 | $3.2B | $12.8B | ||
| Q2 24 | $3.2B | $13.4B | ||
| Q1 24 | $3.3B | $13.4B |
负债/权益比GPORRVTY
| Q4 25 | 0.43× | — | ||
| Q3 25 | 0.38× | — | ||
| Q2 25 | 0.39× | — | ||
| Q1 25 | 0.42× | — | ||
| Q4 24 | 0.41× | — | ||
| Q3 24 | 0.34× | — | ||
| Q2 24 | 0.32× | — | ||
| Q1 24 | 0.29× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $185.4M | $182.0M |
| 自由现金流经营现金流 - 资本支出 | — | $161.8M |
| 自由现金流率自由现金流/营收 | — | 21.0% |
| 资本支出强度资本支出/营收 | — | 2.6% |
| 现金转化率经营现金流/净利润 | 1.40× | 1.85× |
| 过去12个月自由现金流最近4个季度 | — | $509.4M |
8季度趋势，按日历期对齐
经营现金流GPORRVTY
| Q4 25 | $185.4M | $182.0M | ||
| Q3 25 | $209.1M | $138.5M | ||
| Q2 25 | $231.4M | $134.3M | ||
| Q1 25 | $177.3M | $128.2M | ||
| Q4 24 | $148.8M | $174.2M | ||
| Q3 24 | $189.7M | $147.9M | ||
| Q2 24 | $123.5M | $158.6M | ||
| Q1 24 | $188.0M | $147.6M |
自由现金流GPORRVTY
| Q4 25 | — | $161.8M | ||
| Q3 25 | — | $120.0M | ||
| Q2 25 | — | $115.5M | ||
| Q1 25 | — | $112.2M | ||
| Q4 24 | — | $149.8M | ||
| Q3 24 | — | $125.6M | ||
| Q2 24 | — | $136.6M | ||
| Q1 24 | — | $129.7M |
自由现金流率GPORRVTY
| Q4 25 | — | 21.0% | ||
| Q3 25 | — | 17.2% | ||
| Q2 25 | — | 16.0% | ||
| Q1 25 | — | 16.9% | ||
| Q4 24 | — | 20.5% | ||
| Q3 24 | — | 18.4% | ||
| Q2 24 | — | 19.7% | ||
| Q1 24 | — | 20.0% |
资本支出强度GPORRVTY
| Q4 25 | — | 2.6% | ||
| Q3 25 | — | 2.6% | ||
| Q2 25 | — | 2.6% | ||
| Q1 25 | — | 2.4% | ||
| Q4 24 | — | 3.4% | ||
| Q3 24 | — | 3.3% | ||
| Q2 24 | — | 3.2% | ||
| Q1 24 | — | 2.7% |
现金转化率GPORRVTY
| Q4 25 | 1.40× | 1.85× | ||
| Q3 25 | 1.88× | 2.97× | ||
| Q2 25 | 1.25× | 2.49× | ||
| Q1 25 | — | 3.03× | ||
| Q4 24 | — | 1.84× | ||
| Q3 24 | — | 1.57× | ||
| Q2 24 | — | 2.87× | ||
| Q1 24 | 3.61× | 5.67× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
GPOR
| Natural Gas Production | $296.9M | 75% |
| Other | $42.7M | 11% |
| Naturalgasliquidsales | $35.2M | 9% |
| Oil And Condensate | $23.4M | 6% |
RVTY
| Immunodiagnostics | $240.8M | 31% |
| Life Sciences | $191.4M | 25% |
| Reproductive Health | $149.3M | 19% |
| Segment Operating Income | $132.0M | 17% |
| Software | $62.3M | 8% |
